Variables | Overall Survival | Event-free Survival | ||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariable analysis | Univariate analysis | Multivariable analysis | |||||
Hazard ratio(95% confidence interval) | P value | Hazard ratio(95% confidence interval) | P value | Hazard ratio(95% confidence interval) | P value | Hazard ratio(95% confidence interval) | P value | |
Clinicopathological features | ||||||||
 Sex (female) | 0.777(0.538–1.124) | 0.180 |  |  | 0.881(0.624–1.244) | 0.473 |  |  |
 Age(> 60) | 1.084(0.755–1.557) | 0.662 |  |  | 0.872(0.62–1.226) | 0.430 |  |  |
 CEA | 2.155(1.491–3.114) |  < 0.001 | 1.761(1.160–2.674) | 0.008 | 1.691(1.192–2.399) | 0.003 | 1.252(0.841–1.863) | 0.268 |
 CA199 | 1.634(1.121–2.383) | 0.011 | 1.078(0.697–1.668) | 0.735 | 1.691(1.188–2.407) | 0.004 | 0.825(0.558–1.220) | 0.335 |
 Tumor necrosis | 1.721(1.100–2.693) | 0.017 | 1.741(1.083–2.798) | 0.022 | 1.769(1.154–2.712) | 0.009 | 1.598(1.013–2.522) | 0.044 |
Imaging features | ||||||||
 Size (> 5 cm) | 2.715(1.485–3.186) |  < 0.001 | 1.152(0.746–1.777) | 0.524 | 2.488(1.738–3.563) |  < 0.001 | 1.457(0.980–2.166) | 0.063 |
 Tumour multiplicity | 2.432(1.615–3.660) |  < 0.001 | 2.213(1.385–3.537) | 0.001 | 2.190(1.480–3.241) |  < 0.001 | 1.591(1.040–2.435) | 0.032 |
 Lesion contour (infiltrative) | 3.096(2.099–4.565) |  < 0.001 | 2.565(1.633–4.029) |  < 0.001 | 2.745(1.915–3.935) |  < 0.001 | 2.252(1.478–3.432) |  < 0.001 |
 Tumor location (perihilar) | 1.150(0.748–1.768) | 0.526 |  |  | 0.985(0.652–1.487) | 0.943 |  |  |
 Cirrhosis | 0.709(0.410–1.224) | 0.217 |  |  | 0.700(0.415–1.180) | 0.181 |  |  |
 Vascular invasion | 1.775(1.223–2.576) | 0.003 | 1.016(0.653–1.580) | 0.945 | 1.387(0.977–1.969) | 0.068 |  |  |
 Lymph node metastasis | 3.274(2.212–4.845) |  < 0.001 | 2.975(1.903–4.650) |  < 0.001 | 2.566(1.792–3.676) |  < 0.001 | 1.691(1.129–2.531) | 0.011 |
 Bile duct invasion | 1.576(1.089–2.282) | 0.016 | 1.186(0.757–1.860) | 0.457 | 1.217(0.863–1.715) | 0.262 |  |  |
 Arterial enhancement pattern |  |  < 0.001 |  |  < 0.001 |  |  < 0.001 |  |  < 0.001 |
 Hypoenhancement(vs. hyper) | 7.776(4.072–14.847) |  < 0.001 | 5.318(2.564–11.027) |  < 0.001 | 7.018(3.824–12.879) |  < 0.001 | 4.274(2.214–8.251) |  < 0.001 |
 Rim-enhancement(vs. hyper) | 3.820(2.006–7.247) |  < 0.001 | 2.926(1.459–5.866) | 0.002 | 5.010(2.752–9.123) |  < 0.001 | 3.521(1.848–6.708) |  < 0.001 |
 Enhancing capsule | 0.627(0.420–0.936) | 0.022 | 1.806(1.005–3.039) | 0.025 | 0.631(0.435–0.917) | 0.016 | 1.213(0.755–1.948) | 0.425 |
 Delayed enhancement | 0.658(0.424–1.021) | 0.062 |  |  | 1.021(0.691–1.508) | 0.919 |  |  |